BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 20, 2011
View Archived Issues
PLATO subanalysis finds ticagrelor superior to clopidogrel in elderly patients with ACS
Read More
Interim first-in-human data disclosed on BioFreedom biolimus A9-eluting coronary stent
Read More
CTS-1027 shows promise to treat hepatitis C in treatment-naive and -experienced patients
Read More
Preclinical and clinical data presented on GS-9620 for hepatitis B and C
Read More
Cephalon advances in acquisition of ChemGenex Pharmaceuticals
Read More
New antibody-drug conjugate AGS-22M6E may be beneficial for treatment of solid tumors
Read More
Novel PI3K-alpha inhibitors patented by Roche for cancer
Read More
Merck KGaA designs new protein kinase inhibitors
Read More
Galderma synthesizes novel ADAM 17 inhibitors
Read More
Hyaluronidase-4 described as new predictor of bladder cancer progression
Read More
Anaphore's DR4 Atrimers have antitumor activity in vitro
Read More
Oryzon Genomics designs new inhibitors of lysine-specific histone demethylase 1A
Read More
Roche presents new inhibitors of HCV NS3 and NS4A
Read More
Biosearch designs new voltage-gated Na(V)1.3 and Na(V)1.8 sodium channel blockers
Read More
Phase III MARQUEE trial of tivantinib begins enrollment in Europe
Read More
VISTA-16 study of varespladib proceeds as planned after independent biomarker analysis
Read More
Novartis withdraws MAA for Joicela in osteoarthritis
Read More
GSK and Valeant Pharma submit response to FDA on ezogabine
Read More
Bristol-Myers Squibb begins phase I study of BMS-906024 in solid tumors
Read More
Celgene begins phase III trials of pomalidomide in multiple myeloma
Read More
AIDS Healthcare Foundation urges Gilead to halt Truvada approval in HIV prevention
Read More
NicOx withdraws European application for osteoarthritis candidate naproxcinod
Read More
Chugai Pharma receives priority review for Pegasys in new indication in chronic hepatitis B in Japan
Read More
FDA grants orphan status to AM-152 in idiopathic pulmonary fibrosis
Read More
CoDa Therapeutics raises funds for Nexagon trial
Read More